Skip Therapeutics and Sheba Medical Center to Collaborate fo

/PRNewswire/ -- Skip Therapeutics ("Skip"), developer of computational platform for design of Antisense Oligonucleotide (ASO) based therapies and Sheba Medical...

Related Keywords

Israel , Tel Hashomer , Hamerkaz , Rehovot , Ariel Feiglin , Dan Dominissini , Steve Walz , Tsipi Haitovsky , Head Of International Media Public Affairs , Sheba City Of Health , Hematology Laboratory At Sheba Medical Center , Cancer Research , Sheba Medical Center , Antisense Oligonucleotide , Chief Scientific Officer , Hematology Laboratory , Skip Therapeutics , Medical Center , Duchenne Muscular Dystrophy , Batten Disease , Spinal Muscular , Middle East , Best Hospital , International Media , Public Affairs ,